MENU ABOUT US MAKE A DONATION
The Epoch Times
Login
SEARCH
CLOSE
Help Center subscribe newsletter Newsstands Epoch Shop Gift
  • TOP NEWS
  • SPECIAL SERIES
  • SPECIAL COVERAGE
  • LATEST ARTICLES
  • US
    • US News
    • US Features
    • US Politics
    • US Crime News
    • New York
    • San Francisco
    • Los Angeles
  • Opinion
    • Thinking About China
    • Viewpoints
    • Unbridled Evil: The Corrupt Reign of Jiang Zemin in China
    • The Reader’s Turn
  • China News
    • US-China Relations
    • Chinese Regime
    • Business & Economy
    • Chinese Culture
    • China Human Rights
    • Social Issues
    • Organ Harvesting in China
  • World News
    • Africa News
    • Americas
    • Asia & Pacific
    • Canada
    • Europe
    • UK News
    • Australia News
    • International
    • Middle East
  • Business & Markets
    • Companies
    • Economy
    • Markets
    • Real Estate
    • Gold and Commodities
  • ARTS & CULTURE
    • Fine Arts & Craftsmanship
    • Performing Arts
    • Books
    • Traditional Culture
    • Shen Yun Special Coverage
    • Film & TV
  • Science
    • News
    • Space
    • Environment
  • Tech
    • Tech News
    • Tech Products & Reviews
    • Social Media
  • Sports
  • Videos
    • American Thought Leaders
    • China Insider
    • Crossroads
  • Bright
    • Lifestyle
    • Inspired
    • Family & Education
    • Personal Finance
    • American Essence
  • Entertainment
    • Film & TV
    • Entertainment News
  • Health
    • Experts
    • Conditions
    • Life & Wellness
  • Special Topics
    • Battlefields
SEARCH
  • EpochTV
  • US
  • US Politics
  • Opinion
  • World News
  • China
  • Hong Kong
  • Health
  • Bright
  • Arts
  • Falun Gong
  • Premium
  • Markets
  • Games
  • Livestream
  • More

Guillain-Barré syndrome

  • Certain COVID-19 Vaccines Linked to Elevated Risk of Guillain-Barré Syndrome
    Certain COVID-19 Vaccines Linked to Elevated Risk of Guillain-Barré Syndrome
    As the rate of vaccination increases so has the incidence of GBS—particularly after viral vector-based vaccines such as AstraZeneca.
    November 9, 2023BY Ellen Wan
  • Rare Disease Erupts in Peru; WHO to Authenticate Health Records; Surprising Habits That Damage Liver
    Rare Disease Erupts in Peru; WHO to Authenticate Health Records; Surprising Habits That Damage Liver
    The Peruvian government declares a national health emergency due to a rise of a rare autoimmune disease. The ...
    July 22, 2023BY Dan Skorbach
  • Guillain-Barré Syndrome Linked to COVID-19 Vaccine: CDC Study
    Guillain-Barré Syndrome Linked to COVID-19 Vaccine: CDC Study
    A disruptive syndrome may be caused by one of the COVID-19 vaccines available in the United States, U.S. ...
    February 3, 2023BY Zachary Stieber
  • COVID Vax Compensation Recipient ‘Disheartened’ Over Lack of Recognition of the Vaccine Injured
    COVID Vax Compensation Recipient ‘Disheartened’ Over Lack of Recognition of the Vaccine Injured
    Ross Wightman, who was diagnosed with Guillain-Barré syndrome shortly after receiving a dose of the AstraZeneca COVID-19 vaccine, ...
    June 3, 2022BY Lee Harding
  • ‘Significant’ Cases of Neurological Disorder Associated With the AstraZeneca Vaccine
    ‘Significant’ Cases of Neurological Disorder Associated With the AstraZeneca Vaccine
    A UK study by University College London has confirmed “small but significant” cases of the serious Guillain-Barre syndrome ...
    May 31, 2022BY Marina Zhang
  • Rare Nerve Disorder Listed as COVID-19 Vaccine Side Effect by EU
    Rare Nerve Disorder Listed as COVID-19 Vaccine Side Effect by EU
    The European Union's drug regulator listed a rare nerve disorder known as Guillain-Barré syndrome (GBS) as a possible AstraZeneca ...
    September 8, 2021BY Jack Phillips
  • Benefits of Johnson & Johnson COVID-19 Vaccine ‘Continue to Outweigh’ the Risk of Neurological Disorder: CDC Advisory Panel
    Benefits of Johnson & Johnson COVID-19 Vaccine ‘Continue to Outweigh’ the Risk of Neurological Disorder: CDC Advisory Panel
    The vaccine advisory panel to the Centers for Disease Control and Prevention (CDC) said on Thursday that the ...
    July 22, 2021BY Meiling Lee
TOP NEWS
  • Trump Urges Netanyahu Not to Retaliate After Iran’s Missile Attack
    NEW By T.J. Muscaro
    Trump Urges Netanyahu Not to Retaliate After Iran’s Missile Attack
  • America in Photos: USS Iwo Jima Naval Homecoming, Belmont Stakes Horse Race, and Tiananmen Massacre Memorial
    1hr By Epoch Times Staff
    America in Photos: USS Iwo Jima Naval Homecoming, Belmont Stakes Horse Race, and Tiananmen Massacre Memorial
  • Trump on Iran Conflict: Troops Staying Until ‘We Have a Completion’
    5hr By T.J. Muscaro
    Trump on Iran Conflict: Troops Staying Until ‘We Have a Completion’
  • Iran Launches First Missiles at Israel Since Ceasefire Agreement
    6hr By Jacki Thrapp and T.J. Muscaro
    Iran Launches First Missiles at Israel Since Ceasefire Agreement
  • Israel Strikes Beirut Days After US-Supported Ceasefire Announcement
    7hr By Jack Phillips
    Israel Strikes Beirut Days After US-Supported Ceasefire Announcement
  • Former Utah Attorney General Fights the Evil That Lurks in Quiet Places
    7hr By Savannah Hulsey Pointer
    Former Utah Attorney General Fights the Evil That Lurks in Quiet Places
  • US Forces Shoot Down 2 Iranian Drones as Pakistani Interior Minister Visits Tehran
    9hr By Jacki Thrapp
    US Forces Shoot Down 2 Iranian Drones as Pakistani Interior Minister Visits Tehran
  • US Won’t Unfreeze Iran’s Assets Before Peace Deal Is Reached, Trump Says
    10hr By Jacki Thrapp
    US Won’t Unfreeze Iran’s Assets Before Peace Deal Is Reached, Trump Says
  • Fascia: The Living, Interconnected Web Behind Movement and Healing—How to Enhance Its Function
    10hr By Mercura Wang
    Fascia: The Living, Interconnected Web Behind Movement and Healing—How to Enhance Its Function
  • Eli Lilly Poised to Suspend Drug Discounts to Large Hospitals
    14hr By Lawrence Wilson
    Eli Lilly Poised to Suspend Drug Discounts to Large Hospitals
The Epoch Times
Copyright © 2000 - 2026 The Epoch Times Association Inc. All Rights Reserved.
Back Top